CP-601927   Click here for help

GtoPdb Ligand ID: 9056

Synonyms: CP 601927 | CP-601,927
Compound class: Synthetic organic
Comment: CP-601927 is an orally available, CNS‐penetrant, high affinity, selective, investigational partial agonist of the nicotinic acetylcholine (nAch) receptor α4β2 [1], developed for its potential in several central nervous system conditions [3]. CP-601927 was investigated for its potential to augment antidepressant treatment in patients with major depressive disorder [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 12.03
Molecular weight 227.09
XLogP 2.35
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC(c1ccc2c(c1)C1CNCC2C1)(F)F
Isomeric SMILES FC(c1ccc2c(c1)[C@H]1CNC[C@@H]2C1)(F)F
InChI InChI=1S/C12H12F3N/c13-12(14,15)9-1-2-10-7-3-8(6-16-5-7)11(10)4-9/h1-2,4,7-8,16H,3,5-6H2/t7-,8+/m0/s1
InChI Key RNOBTWYQAWEZHH-JGVFFNPUSA-N
Bioactivity Comments
Administration of CP-601927 potentiates the effects of sertraline and fluoxetine in mice.
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
nicotinic acetylcholine receptor α2 subunit Primary target of this compound Hs Agonist Partial agonist 8.9 pKi - 3
pKi 8.9 (Ki 1.2x10-9 M) [3]
Description: Measured against α2β4 nAchRs- species not identified.